Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04150887
Title Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

acute myeloid leukemia

Therapies

ARGX-110 + Azacitidine + Venetoclax

ARGX-110 + Venetoclax

ARGX-110 + Azacitidine

Age Groups: adult | senior
Covered Countries USA | DEU | CAN


No variant requirements are available.